Integrated Approaches Revealed the Therapeutic Mechanisms of Zuojin Pill Against Gastric Mucosa Injury in a Rat Model with Chronic Atrophic Gastritis.
Li-Sheng ChenTingting HeRuilin WangHonghong LiuXin WangHaotian LiManyi JingXuelin ZhouShizhang WeiWenjun ZouYanling ZhaoPublished in: Drug design, development and therapy (2024)
Our study revealed that ZJP treats CAG by inhibiting the PI3K/Akt signaling pathway. This research provided a scientific basis for the rational use of ZJP in clinical practice.